Fatal COVID-19 in a Child with Persistence of SARS-CoV-2 Despite Extensive Multidisciplinary Treatment: A Case Report

Critical Coronavirus disease 2019 (COVID-19) developed in a 7-year-old girl with a history of dystrophy, microcephaly, and central hypothyroidism. Starting with gastrointestinal symptoms, the patient developed severe myocarditis followed by progressive multiple organ failure complicated by Pseudomonas aeruginosa bloodstream infection. Intensive care treatment consisting of invasive ventilation, drainage of pleural effusion, and high catecholamine therapy could not prevent the progression of heart failure, leading to the implantation of venoarterial extracorporeal life support (VA-ECLS) and additional left ventricle support catheter (Impella® pump). Continuous venovenous hemofiltration (CVVH) and extracorporeal hemadsorption therapy (CytoSorb®) were initiated. Whole exome sequencing revealed a mutation of unknown significance in DExH-BOX helicase 30 (DHX30), a gene encoding a RNA helicase. COVID-19 specific antiviral and immunomodulatory treatment did not lead to viral clearance or control of hyperinflammation resulting in the patient’s death on extracorporeal life support-(ECLS)-day 20. This fatal case illustrates the potential severity of pediatric COVID-19 and suggests further evaluation of antiviral treatment strategies and vaccination programs for children.

[1]  M. Aepfelbacher,et al.  Evaluation of a fully automated high-throughput SARS-CoV-2 multiplex qPCR assay with built-in screening functionality for del-HV69/70- and N501Y variants such as B.1.1.7 , 2021, Journal of Clinical Virology.

[2]  C. Bode,et al.  Hemoadsorption eliminates remdesivir from the circulation: Implications for the treatment of COVID‐19 , 2021, Pharmacology research & perspectives.

[3]  R. Bhopal,et al.  Children and young people remain at low risk of COVID-19 mortality , 2021, The Lancet Child & Adolescent Health.

[4]  M. Oster,et al.  Factors linked to severe outcomes in multisystem inflammatory syndrome in children (MIS-C) in the USA: a retrospective surveillance study , 2021, The Lancet Child & Adolescent Health.

[5]  S. Dominguez,et al.  Risk Factors for Severe COVID-19 in Children. , 2021, The Pediatric infectious disease journal.

[6]  I. Jordan,et al.  Severe manifestations of SARS-CoV-2 in children and adolescents: from COVID-19 pneumonia to multisystem inflammatory syndrome: a multicentre study in pediatric intensive care units in Spain , 2020, Critical Care.

[7]  A. Iwasaki,et al.  Interferon deficiency can lead to severe COVID , 2020, Nature.

[8]  F. Kirchhoff,et al.  SARS-CoV-2 Is Restricted by Zinc Finger Antiviral Protein despite Preadaptation to the Low-CpG Environment in Humans , 2020, mBio.

[9]  Bartholomew White,et al.  Acute Brain Injury in Infant Venoarterial Extracorporeal Membrane Oxygenation: An Autopsy Study. , 2020, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[10]  Steven M. Holland,et al.  Autoantibodies against type I IFNs in patients with life-threatening COVID-19 , 2020, Science.

[11]  Jacques Fellay,et al.  Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 , 2020, Science.

[12]  M. Aepfelbacher,et al.  Pushing beyond specifications: Evaluation of linearity and clinical performance of the cobas 6800/8800 SARS-CoV-2 RT-PCR assay for reliable quantification in blood and other materials outside recommendations , 2020, Journal of Clinical Virology.

[13]  R. Bhopal,et al.  COVID-19 deaths in children: comparison with all- and other causes and trends in incidence of mortality , 2020, Public Health.

[14]  M. Heller,et al.  [Postmortem imaging of the lung in cases of COVID-19 deaths]. , 2020, Der Radiologe.

[15]  J. Newburger,et al.  Cardiac manifestations in SARS-CoV-2-associated multisystem inflammatory syndrome in children: a comprehensive review and proposed clinical approach , 2020, European Journal of Pediatrics.

[16]  Victor G. Puelles,et al.  SARS-CoV-2 renal tropism associates with acute kidney injury , 2020, The Lancet.

[17]  C. Murray,et al.  COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study , 2020, The Lancet Child & Adolescent Health.

[18]  J. Casanova,et al.  Severe COVID-19 in the young and healthy: monogenic inborn errors of immunity? , 2020, Nature Reviews Immunology.

[19]  G. di Perri,et al.  Development and validation of a UHPLC-MS/MS method for quantification of the prodrug remdesivir and its metabolite GS-441524: a tool for clinical pharmacokinetics of SARS-CoV-2/COVID-19 and Ebola virus disease , 2020, The Journal of antimicrobial chemotherapy.

[20]  C. Ronco,et al.  Kidney involvement in COVID-19 and rationale for extracorporeal therapies , 2020, Nature Reviews Nephrology.

[21]  Zhongyi Jiang,et al.  Epidemiology of COVID-19 Among Children in China , 2020, Pediatrics.

[22]  Vinodh Narayanan,et al.  De Novo Missense Mutations in DHX30 Impair Global Translation and Cause a Neurodevelopmental Disorder. , 2018, American journal of human genetics.

[23]  W. Dreyer,et al.  Percutaneous Mechanical Circulatory Support Using Impella Devices for Decompensated Cardiogenic Shock: A Pediatric Heart Center Experience , 2017, ASAIO journal.